Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

398 ARTÍCULOS , VIENDO DEL 46 AL 60

Drug Development for Alzheimer's Disease: Microglia Induced Neuroinflammation as a Target?

Dong Y, Li X, Cheng J, Hou L.

Int J Mol Sci. 2019 Jan 28;20(3):558. doi: 10.3390/ijms20030558.

Are antibodies directed against amyloid-β (Aβ) oligomers the last call for the Aβ hypothesis of Alzheimer's disease?

Panza F, Lozupone M, Dibello V, Greco A, Daniele A, Seripa D, Logroscino G, Imbimbo BP.

Immunotherapy. 2019 Jan;11(1):3-6. doi: 10.2217/imt-2018-0119.

Target Enzyme in Alzheimer's Disease: Acetylcholinesterase Inhibitors

Saxena M, Dubey R.

Curr Top Med Chem. 2019;19(4):264-275. doi: 10.2174/1568026619666190128125912.

New evolutions in the BACE1 inhibitor field from 2014 to 2018

Hsiao CC, Rombouts F, Gijsen HJM.

Bioorg Med Chem Lett. 2019 Mar 15;29(6):761-777. doi: 10.1016/j.bmcl.2018.12.049. Epub 2019 Jan 4.

Targeting amyloid clearance in Alzheimer's disease as a therapeutic strategy

Nalivaeva NN, Turner AJ.

Br J Pharmacol. 2019 Sep;176(18):3447-3463. doi: 10.1111/bph.14593. Epub 2019 Mar 11.

Autophagy in Alzheimer's disease and promising modulatory effects of herbal medicine

Zeng Q, Siu W, Li L, Jin Y, Liang S, Cao M, Ma M, Wu Z.

Exp Gerontol. 2019 May;119:100-110. doi: 10.1016/j.exger.2019.01.027. Epub 2019 Jan 30.

Small Molecule Natural Products and Alzheimer's Disease

Wu X, Cai H, Pan L, Cui G, Qin F, Li Y, Cai Z.

Curr Top Med Chem. 2019;19(3):187-204. doi: 10.2174/1568026619666190201153257.

Therapeutic noninvasive brain stimulation in Alzheimer's disease and related dementias

Buss SS, Fried PJ, Pascual-Leone A.

Curr Opin Neurol. 2019 Apr;32(2):292-304. doi: 10.1097/WCO.0000000000000669.

MicroRNAs for the Treatment of Dementia and Alzheimer's Disease

Maiese K.

Curr Neurovasc Res. 2019;16(1):1-2. doi: 10.2174/1567202616666190208094159.

Scope of new formulation approaches in the repurposing of pioglitazone for the management of Alzheimer's disease

Jojo GM, Kuppusamy G.

J Clin Pharm Ther. 2019 Jun;44(3):337-348. doi: 10.1111/jcpt.12808. Epub 2019 Feb 9.

Tacrines for Alzheimer's disease therapy. III. The PyridoTacrines

de Los Ríos C, Marco-Contelles J.

Eur J Med Chem. 2019 Mar 15;166:381-389. doi: 10.1016/j.ejmech.2019.02.005. Epub 2019 Feb 4.

Potential Astrocytic Receptors and Transporters in the Pathogenesis of Alzheimer's Disease

Zhang X, Lao K, Qiu Z, Rahman MS, Zhang Y, Gou X.

J Alzheimers Dis. 2019;67(4):1109-1122. doi: 10.3233/JAD-181084.

Anti-cholinesterase hybrids as multi-target-directed ligands against Alzheimer's disease (1998-2018)

Mishra P, Kumar A, Panda G.

Bioorg Med Chem. 2019 Mar 15;27(6):895-930. doi: 10.1016/j.bmc.2019.01.025. Epub 2019 Jan 25.

The Effectiveness of Vitamin E Treatment in Alzheimer's Disease

Lloret A, Esteve D, Monllor P, Cervera-Ferri A, Lloret A.

Int J Mol Sci. 2019 Feb 18;20(4):879. doi: 10.3390/ijms20040879.

Comparative Serum Proteomic Analysis of the Effects of Sodium Selenate on a Mouse Model of Alzheimer's Disease

Chen P, Wang LX, Sui XJ, Li SM, Wang Y, Liu Q, Ni JZ.

Biol Trace Elem Res. 2019 Dec;192(2):263-276. doi: 10.1007/s12011-019-01676-9. Epub 2019 Feb 21.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias